Blood Poisoning of Cancer Patients Resulting from the Use of Paisali Containing Mixed Cannabis
Main Article Content
Abstract
Introduction: The prevalence of cancer patients seeking the Paisali formula from researchers in collaboration with Khu Muang Hospital during the year 2022 reflects the cancer patients’ inclination towards exploring herbal remedies for cancer treatment. Methods: This study aimed to investigate the effectiveness of the Paisali formula in alleviating vomiting and hematological toxicity in cancer patients using an experimental approach. The study comprised a total of 400 participants divided into two groups: an experimental group of 200 individuals receiving the Paisali drug and a control group of 200 individuals receiving a placebo. Throughout the study, toxicity levels were evaluated through laboratory blood tests conducted five times at 30-day intervals, and the results underwent independent t-test analysis. Results: The experimental group, which received 200 mg of Paisali, exhibited a statistically significant reduction in post-chemotherapy vomiting (p<0.00). Additionally, a comparison of blood test results before and after the administration of Paisali between the experimental and control groups revealed noteworthy differences in hydrogen ion concentration, hemoglobin levels, hematocrit, neutrophil count, alkaline phosphatase, aspartate transaminase, total bilirubin, and blood sugar values (p<0.00), as well as white blood cell values (p<0.02). These results suggest that the Paisali formula not only effectively reduced vomiting but also ameliorated hematological toxicity when compared to standard treatment alone. Conclusion: This study offers valuable insights into the potential advantages of incorporating the Paisali formula as an additional treatment option for managing chemotherapy-induced side effects in cancer patients. However, further research is necessary to comprehensively explore its mechanisms and long-term effects.
Downloads
Article Details
References
Abeysekara S, Zello GA, Lohmann KL, Alcorn J, Hamilton DL, Naylor JM. Infusion of sodium bicarbonate in experimentally induced metabolic acidosis does not provoke cerebrospinal fluid (CSF) acidosis in calves. Can J Vet Res. 2012;76(1):16-22.
Achanti A, Szerlip HM. Acid-Base Disorders in the Critically Ill Patient. Clin J Am Soc Nephrol. 2023;18(1):102-112. doi: 10.2215/CJN.04500422.
Abad K, Kien C, Ganta K. A unique case of metformin-associated severe lactic acidosis without preexisting renal disease: perspectives on prolonged dialysis and education for prevention. Cureus. 2020;12(4). doi: 10.7759/cureus.7564.
Goonoo MS, Morris R, Raithatha A, Creagh F. Metformin-associated lactic acidosis: reinforcing learning points. BMJ Case Rep CP. 2020;13(9):e235608. doi: 10.1136/bcr-2020-235608.
Judge BS. Differentiating the causes of metabolic acidosis in the poisoned patient. Clinics in Laboratory Medicine. 2006;26(1):31-48. doi: 10.1016/j.cll.2006.01.002.
Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6(1):40. doi: 10.1038/s41572-020-0165-1.
Berend K, Duits AJ. The role of the clinical laboratory in diagnosing acid-base disorders. Crit Rev Clin Lab Sci. 2019;56(3):147-169. doi: 10.1080/10408363.2019.1568965.
Rudkin SE, Grogan TR, Treger RM. The Δ anion gap/Δ bicarbonate ratio in early lactic acidosis: time for another delta? Kidney360. 2021;2(1):20. doi: 10.34067/KID.0000842019.
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003.
Ang SP, Sidharthan S, Lai W, Hussain N, Patel KV, Gulati A, et al. Cannabinoids as a potential alternative to opioids in the management of various pain subtypes: Benefits, limitations, and risks. Pain Ther. 2023;12(2):355-375. doi: 10.1007/s40122-022-00465-y.
Edinoff AN, Wu NW, Nix CA, Bonin B, Mouhaffel R, Vining S, et al. Historical pathways for opioid addiction, withdrawal with traditional and alternative treatment options with ketamine, cannabinoids, and noribogaine: a narrative review. Health Psychol Res. 2022;10(4). doi: 10.52965/001c.38672.
Kansagara D, Becker WC, Ayers C, Tetrault JM. Priming primary care providers to engage in evidence-based discussions about cannabis with patients. Addict Sci Clin Pract. 2019;14:42. doi: 10.1186/s13722-019-0171-3.
Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. British Journal of Clinical Pharmacology. 2018;84(11): 2477-2482. doi: 10.1111/bcp.13710.
Gussow L. Toxicology Rounds: Should EPs Worry about CBD Toxicity? Emerg Med News. 2020 Mar;42(3):17. doi: 10.1097/01.EEM.0000657672.65371.f2.
Smith RT, Gruber SA. Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions. Front Psychiatry. 2023;13:1055481. doi: 10.3389/fpsyt.2022.1055481.
Khan H, Singh A, Thapa K, Garg N, Grewal AK, Singh TG. Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury. Brain Res. 2021;1761:147399. doi: 10.1016/j.brainres.2021.147399.
Sadowska O, Baranowska-Kuczko M, Gromotowicz-Popławska A, Biernacki M, Kicman A, Malinowska B, et al. Cannabidiol ameliorates monocrotaline-induced pulmonary hypertension in rats. Int J Mol Sci. 2020;21(19):7077. doi: 10.3390/ijms21197077.
Bara A, Ferland JN, Rompala G, Szutorisz H, Hurd YL. Cannabis and synaptic reprogramming of the developing brain. Nat Rev Neurosci. 2021;22(7):423-438. doi: 10.1038/s41583-021-00465-5.
White CM. A review of human studies assessing cannabidiol’s (CBD) therapeutic actions and potential. J Clin Pharmacol. 2019;59(7):923-934. doi: 10.1002/jcph.1387.
Alsherbiny MA, Li CG. Medicinal Cannabis-Potential Drug Interactions. Medicines (Basel). 2018;6(1):3. doi: 10.3390/medicines6010003.
Brown JD. Potential adverse drug events with tetrahydrocannabinol (THC) due to drug-drug interactions. J Clin Med. 2020;9(4):919. doi: 10.3390/jcm9040919.
Pham AQT, Xu LHR, Moe OW. Drug-Induced Metabolic Acidosis. F1000Research. 2015;4:1460. doi: 10.12688/f1000research.7006.1.
Saudubray JM, García-Cazorla Á. Clinical approach to inborn errors of metabolism in pediatrics. In: Blau N, Duran M, Gibson KM, editors. Inborn Metabolic Diseases: Diagnosis and Treatment. Berlin, Heidelberg: Springer Berlin Heidelberg. 2022;3-123. doi: 10.1007/978-3-662-63123-2_1.
Buinitskaya Y, Gurinovich R, Wlodaver CG, Kastsiuchenka S. Centrality of G6PD in COVID-19: the biochemical rationale and clinical implications. Front Med. 2020;7:584112. doi: 10.3389/fmed.2020.584112.
Long B, Lentz S, Gottlieb M. Alcoholic ketoacidosis: Etiologies, evaluation, and management. J Emerg Med. 2021;61(6):658-665. doi: 10.1016/j.jemermed.2021.09.007.
Iam-am A, Thippayacharoentam T, Thippayacharoentam C, Chaiworaslip W, Duangdee T. Analytical Study of Herbal Medicine in Phrom P’Rohit Scripture. Damrong Journal of The Faculty of Archaeology Silpakorn University. 2018;17(2).
Fabre V, Carroll KC, Cosgrove SE. Blood Culture Utilization in the Hospital Setting: a Call for Diagnostic Stewardship. J Clin Microbiol. 2022;60(3):e0100521. doi: 10.1128/JCM.01005-21.
Marshall WJ, Lapsley M, Day A, Shipman K. Clinical Chemistry. 9th ed. Elsevier Health Sciences; 2020.
Zhang Y, Liang F, Zhang D, Qi S, Liu Y. Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study for diagnostic and therapeutic purposes. Biomed Pharmacother. 2023;157:114046. doi: 10.1016/j.biopha.2022.114046.
Penman ID, Ralston SH, Strachan MW, Hobson R. Davidson’s Principles and Practice of Medicine E-Book. 24th ed. Elsevier Health Sciences; 2022.
Jangjou A, Moqadas M, Mohsenian L, Kamyab H, Chelliapan S, Alshehery S, et al. Awareness raising and dealing with methanol poisoning based on effective strategies. Environ Res. 2023;228:115886. doi: 10.1016/j.envres.2023.115886.
Fujii T, Udy AA, Nichol A, Bellomo R, Deane AM, El-Khawas K, et al. Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: An international observational study. Critical Care (London, England). 2021;25(1):45. doi: 10.1186/s13054-020-03431-2.
Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008.
Maayah ZH, Takahara S, Ferdaoussi M, Dyck JR. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflamm Res. 2020;69:549-558. doi: 10.1007/s00011-020-01341-1.
Kang JS, Lee MH. Overview of Therapeutic Drug Monitoring. The Korean Journal of Internal Medicine. 2009;24(1): 1-10. doi: 10.3904/kjim.2009.24.1.1.
Ghali M, Bensted K, Williams DB, Ghaly S. Type 2 autoimmune pancreatitis associated with severe ulcerative colitis: Three case reports. World J Clin Cases. 2022;10(24):8788. doi: 10.12998/wjcc.v10.i24.8788.
Cole EJ, Phillips AL, Bentzley BS, Stimpson KH, Nejad R, Barmak F, et al. Stanford neuromodulation therapy (SNT): A double-blind randomized controlled trial. Am J Psychiatry. 2022;179(2):132-141. doi: 10.1176/appi.ajp.2021.20101429.
Sharma SK, Mudgal SK, Thakur K, Gaur R. How to calculate sample size for observational and experimental nursing research studies? Natl JPhysiol Pharm Pharmacol. 2020;10(01):1-8.
Bhardwaj P. Types of sampling in research. J Pract Cardiovasc Sci. 2019;5(3):157. doi: 10.4103/jpcs.jpcs_62_19.
Heuer C, Stevenson MA. Diagnostic test validation studies when there is a perfect reference standard. Revue Scientifique et Technique (International Office of Epizootics). 2021;40(1):261-270. doi: 10.20506/rst.40.1.3223.
Lee SW. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2022;2. doi: 10.54724/lc.2022.e1.
Grimison P, Mersiades A, Kirby A, Lintzeris N, Morton R, Haber P, et al. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Ann Oncol. 2020;31(11):1553-1560. doi: 10.1016/j.annonc.2020.07.020.
Bolshakova M, Bluthenthal R, Sussman S. Opioid use and misuse: health impact, prevalence, correlates and interventions. Psychol Health. 2019;34(9):1105-1139. doi: 10.1080/08870446.2019.1622013.
Mills L, Lintzeris N, O’Malley M, Arnold JC, McGregor IS. Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. Drug Alcohol Rev. 2022;41(5):1095-1108. doi: 10.1111/dar.13444.
Krasner S. Gender Differences in Cannabis Vaporizer Use [dissertation]. Palo Alto University; 2020.
Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med. 2017;6(Suppl 2):S215-S222. doi: 10.21037/apm.2017.08.05.
Ross M. Kratom is Medicine: Natural Relief for Anxiety, Pain, Fatigue, and More. GreenStone Books; 2021.
Rafei P, Englund A, Lorenzetti V, Elkholy H, Potenza MN, Baldacchino AM. Transcultural Aspects of Cannabis Use: a Descriptive Overview of Cannabis Use across Cultures. Curr Addict Rep. 2023. doi: 10.1007/s40429-023-00500-8.
McHugh MJ, McGorry PD, Yung AR, Lin A, Wood SJ, Hartmann JA, et al. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis. Psychological Medicine. 2017;47(4):616-626. doi: 10.1017/S0033291716002671.
Marconi A, Di Forti M, Lewis CM, Murray RM, Vassos E. Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. Schizophrenia Bulletin. 2016;42(5):1262-1269. doi: 10.1093/schbul/sbw003